AbL Diagnostics SA (ABLD) — Cash Flow Reinvestment Rate
AbL Diagnostics SA (ABLD) has a Cash Flow Reinvestment Rate of 0.84x as of June 2025, reinvesting €400.39K (capex €400.39K ) from operating cash flow of €479.46K. See cash generation quality of AbL Diagnostics SA to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AbL Diagnostics SA Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for AbL Diagnostics SA across 5 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of AbL Diagnostics SA.
Annual Cash Flow Reinvestment Rate for AbL Diagnostics SA (2017–2025)
Year-by-year capital reinvestment analysis for AbL Diagnostics SA. See financial flexibility index of AbL Diagnostics SA to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | €792.67K | €1.51 Million | €792.67K | ▼ -48.1% |
| 2023 | 1.01x | €938.50K | €926.43K | €938.50K | — |
| 2020 | 0.00x | €0.00 | €29.51K | €0.00 | ▼ -100.0% |
| 2018 | 7.95x | €644.40K | €81.10K | €644.40K | ▲ +1658.8% |
| 2017 | 0.45x | €305.02K | €675.20K | €305.02K | — |